Key result
Right ventricular ejection fraction derived from an ellipsoid model was not inferior to TAPSE and RVFAC in predicting all-cause mortality in acute heart failure.
Why the study?
Established echocardiographic parameters fail to reflect global RV volumes, and calculating RV volumes and RVEF using an ellipsoid geometric model had not been validated in HF patients.
Does RVEF/E derived from an ellipsoid model predict all-cause mortality compared to TAPSE and RVFAC in patients with acute heart failure?
Cross-Sectional (n=418)
No
Does RVEF/E derived from an ellipsoid model predict all-cause mortality compared to TAPSE and RVFAC in patients with acute heart failure?
RVEF/E derived from an ellipsoid model is a valid prognostic indicator of outcome in acute heart failure, comparable to established measures like TAPSE and RVFAC.
Answers are grounded in this paper and cite their sources.
RVEF/E from ellipsoid model is not inferior to TAPSE/RVFAC for acute HF prognosis; leaves open routine adoption pending prospective validation.
OBJECTIVES: The right ventricular (RV) function is an important prognostic factor in acute and chronic heart failure (HF). Echocardiography is an essential imaging modality with established parameters for RV function which are useful and easy to perform. However, these fail to reflect global RV volumes due to reliability on one acoustic window. It is therefore attractive to calculate RV volumes and ejection fraction (RVEF/E) using an ellipsoid geometric model which has been validated against MRI in healthy adults but not in the HF patients. DESIGN: This is a retrospective analysis of a prospective cross-sectional study enrolling 418 consecutive patients with symptoms of HF according to a predefined study protocol. All patients underwent echocardiographic assessment of RV function using Tricuspid Annular Plane Systolic Excursion (TAPSE) and RV fractional area change (RVFAC) and RVEF/E. SETTING: Single centre study with multiple locations for acute in-patients including high dependency units. PARTICIPANTS: Patients with acute or exacerbation of chronic HF older than 18 y.o. MAIN OUTCOME MEASURES: Ability of RVEF/E to predict patient outcomes compared with two established parameters of RV function over two-year follow-up period. Primary outcome measure was all-cause mortality. RESULTS: RVEF/E is equal to TAPSE & RVFAC in predicting outcome (p ≤ 0.01 vs p ≤ 0.01) and provides additional benefit of RV volume estimation based on standard 2D echo measurements. CONCLUSIONS: In this study we have shown that RVEF/E derived from ellipsoid model is not inferior to well established measures of RV function as a prognostic indicator of outcome in the acute HF.
No takes yet. Share an insight, caveat, or question.
Ashcroft et al. (2021) conducted a cross-sectional in Acute heart failure (n=418). Right ventricular ejection fraction (RVEF/E) using an ellipsoid geometric model vs. Tricuspid Annular Plane Systolic Excursion (TAPSE) and RV fractional area change (RVFAC) was evaluated on All-cause mortality (p=≤0.01). Right ventricular ejection fraction derived from an ellipsoid model was not inferior to TAPSE and RVFAC in predicting all-cause mortality in acute heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: